[{"id":"14077522-c4f9-49b8-a790-5ed5d6ceade7","acronym":"","url":"https://clinicaltrials.gov/study/NCT04928612","created_at":"2025-03-03T15:59:29.814Z","updated_at":"2025-03-03T15:59:29.814Z","phase":"Phase 1","brief_title":"A Study of CBP-1018 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT04928612","lead_sponsor":"Coherent Biopharma (Suzhou) Co., Ltd.","biomarkers":" FOLR1","pipe":"","alterations":" ","tags":["FOLR1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CBP-1018"],"overall_status":"Recruiting","enrollment":" Enrollment 170","initiation":"Initiation: 11/04/2021","start_date":" 11/04/2021","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-08-28"}]